Identifying and counseling women at increased risk for breast cancer

Mayo Clinic Proceedings

Volumn 77, Issue 4, 2002, Pages 355-361

  Rhodes, Deborah J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CANCER RISK; CHEMOPROPHYLAXIS; COMPUTER ANALYSIS; FAMILY HISTORY; FEMALE; HUMAN; LIFESTYLE; MASTECTOMY; OVARIECTOMY; PATIENT COUNSELING; RISK ASSESSMENT; SHORT SURVEY;

EID: 0036199889     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.4.355     Document Type: Review

References (29)

1. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age
2. Effects of individualized breast cancer risk counseling: A randomized trial
3. Perception of breast cancer risk among women in breast center and primary care settings: Correlation with age and family history of breast cancer
4. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
5. Benign breast changes and the risk for subsequent breast cancer: An update of the 1985 consensus statement
6. Validation studies for models projecting the risk of invasive and total breast cancer incidence
7. Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction
8. Agreement between breast cancer risk estimation methods
9. Recommendations for follow-up care of individuals with an inherited predisposition to cancer II: BRCA1 and BRCA2
10. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk
11. Associations between energy balance, and body mass index and risk of breast carcinoma in women from diverse racial ethnic backgrounds in the U.S.
12. Dual effects of weight and weight gain on breast cancer risk
13. Design of the Women's Health Initiative clinical trial and observational study
14. Alcohol and breast cancer in women: A pooled analysis of cohort studies
15. Physical activity and the risk of breast cancer
16. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
17. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
18. Estrogen replacement therapy in women with a history of proliferative breast disease
19. Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk
20. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer
21. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer
22. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
23. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
24. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women: Italian Tamoxifen Prevention study
25. Breast cancer prevention trials
26. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial
27. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
28. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers